PROCESSA PHARMACEUTICALS, INC.

Analyst Reco. Processa Pharmaceuticals, Inc.

Equities

PCSA

US74275C3043

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-14 pm EDT			5-day change	1st Jan Change
1.75 ^USD	+5.78%		-1.13%	-73.85%

Jun. 11	Processa Pharmaceuticals, Inc. Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1B Dose-Escalating Trial with Ngc-Cap in Gastrointestinal Cancer	CI
Jun. 07	Top Premarket Decliners	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Gainers	Apr. 25	MT
HC Wainwright Starts Processa Pharmaceuticals With Buy Rating, $8 Price Target	Apr. 25	MT
Benchmark Adjusts Price Target on Processa Pharmaceuticals to $4 From $9, Keeps Speculative Buy Rating	23-04-04	MT
Oppenheimer Adjusts Processa Pharmaceuticals Price Target to $3 From $5, Maintains Outperform Rating	23-04-03	MT
Maxim Adjusts Price Target on Processa Pharmaceuticals to $5 From $9, Maintains Buy Rating	23-01-12	MT
Oppenheimer Adjusts Processa Pharmaceuticals' Price Target to $11 From $17, Maintains Outperform Rating	22-08-15	MT
Maxim Initiates Processa Pharmaceuticals at Buy with $9 Price Target	22-04-19	MT
PROCESSA PHARMACEUTICALS : Oppenheimer Starts Processa Pharmaceuticals at Outperform With $20 Price Target	21-08-03	MT
PROCESSA PHARMACEUTICALS : Benchmark Starts Processa Pharmaceuticals at Buy with $15 Price Target	20-12-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer